Literature DB >> 15354392

Worsened motor test performance following acute apomorphine injection in previously untreated patients with Parkinson's disease.

Th Müller1, S Benz, Ch Börnke, S Muhlack, D Woitalla, H Przuntek.   

Abstract

Instrumental tests and clinical rating assess motor disability in Parkinson's disease (PD) patients. Previous long-term dopaminergic substitution influences the behaviour following acute dopaminergic stimulation. Objective of this study was to investigate the motor response following an apomorphine application in previously untreated-, treated- and before treated PD patients, who received placebo. Outcomes of instrumental tests worsened in previously untreated-, but not in before treated PD patients after apomorphine injection and in the PD subjects under the placebo condition. Generally, rating scores of motor symptoms significantly improved after apomorphine administration, whereas placebo application showed no effects. Tolerance to sedative effects of apomorphine in treated PD patients or sensitivity of employed motor tests to presynaptic dopaminergic autoreceptor mediated inhibition of endogenous dopamine release or postsynaptic dopaminergic overstimulation with resulting decreased cognitive function in previously untreated PD patients hypothetically caused this discrepancy between outcomes of subjective clinical rating and objective motor test performance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15354392     DOI: 10.1007/978-3-7091-0579-5_9

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  1 in total

1.  Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.

Authors:  Franziska Richter; Fuying Gao; Vera Medvedeva; Patrick Lee; Nicholas Bove; Sheila M Fleming; Magali Michaud; Vincent Lemesre; Stefano Patassini; Krystal De La Rosa; Caitlin K Mulligan; Pedrom C Sioshansi; Chunni Zhu; Giovanni Coppola; Thierry Bordet; Rebecca M Pruss; Marie-Françoise Chesselet
Journal:  Neurobiol Dis       Date:  2014-05-18       Impact factor: 5.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.